An integrated approach for the in vitro dosimetry of engineered nanomaterials
about
Toxicological assessment of CoO and La2O3 metal oxide nanoparticles in human small airway epithelial cellsSmall airway epithelial cells exposure to printer-emitted engineered nanoparticles induces cellular effects on human microvascular endothelial cells in an alveolar-capillary co-culture modelEffects of Laser Printer–Emitted Engineered Nanoparticles on Cytotoxicity, Chemokine Expression, Reactive Oxygen Species, DNA Methylation, and DNA DamageGenotoxicity and carcinogenic potential of carbon nanomaterialsDirect stimulation of human fibroblasts by nCeO2 in vitro is attenuated with an amorphous silica coatingCurrent understanding of interactions between nanoparticles and the immune systemNanomaterials in consumer products: a challenging analytical problemAt the Crossroads of Nanotoxicology in vitro: Past Achievements and Current ChallengesHow should the completeness and quality of curated nanomaterial data be evaluated?An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicologyComparative lung toxicity of engineered nanomaterials utilizing in vitro, ex vivo and in vivo approachesIn vivo epigenetic effects induced by engineered nanomaterials: A case study of copper oxide and laser printer-emitted engineered nanoparticlesQuantification of the cellular dose and characterization of nanoparticle transport during in vitro testingQuantitative Profiling of Protein S-Glutathionylation Reveals Redox-Dependent Regulation of Macrophage Function during Nanoparticle-Induced Oxidative StressImplications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterialsParacelsus in nanotoxicologyEffect of sonication on particle dispersion, administered dose and metal release of non-functionalized, non-inert metal nanoparticles.Linking Exposures of Particles Released From Nano-Enabled Products to Toxicology: An Integrated Methodology for Particle Sampling, Extraction, Dispersion, and DosingAdvanced computational modeling for in vitro nanomaterial dosimetryBuoyant Nanoparticles: Implications for Nano-Biointeractions in Cellular StudiesShort-term exposure to engineered nanomaterials affects cellular epigenomeSerum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell ModelsComprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing StrategyHigh resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technologyAir-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensionsEvaluation of tumorigenic potential of CeO2 and Fe2O3 engineered nanoparticles by a human cell in vitro screening modelSelection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silica.Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniquesSimulation tool for assessing the release and environmental distribution of nanomaterialsAssessment of a panel of interleukin-8 reporter lung epithelial cell lines to monitor the pro-inflammatory response following zinc oxide nanoparticle exposure under different cell culture conditionsPulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies.A critical review of in vitro dosimetry for engineered nanomaterials.Methodologies and approaches for the analysis of cell-nanoparticle interactions.A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials.Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines.The virtual cell based assay: Current status and future perspectives.Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials.Impact of serum as a dispersion agent for in vitro and in vivo toxicological assessments of TiO2 nanoparticles.Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols.
P2860
Q23914650-DE1407D1-9CC1-4471-BEDB-B1AB932DD7A4Q23914652-E673A7C5-D05F-410A-8FE8-4D2D4041F0ACQ23921025-C39792A8-B412-44EC-B22B-713161956684Q26322763-70211610-003F-4491-803F-2D9E74FA2C47Q26343837-B448BB07-781E-490A-8C67-6E7F45F4CD8BQ26345204-F88ACB6F-0463-4D02-B46D-8A9842624BECQ26795365-F2ADFDA6-D1C1-4635-B6A3-6DECA28787DCQ26796677-CBBEF755-0243-441A-9B58-B841194D6431Q27908490-1E979BA1-1876-4E25-999B-EC08D26EDA3EQ27942681-F9AFD930-EB7A-4F6B-BEB0-1B808464C320Q28383965-361DD5A3-A0CC-4BD6-AF5F-52D5643EB5B6Q28384796-3F3ACABD-1D6F-4A02-96EA-F9DF9D67CB08Q28387370-4AD6DCB6-69FE-47E5-8DDD-C2B20CB51099Q28387613-4ABA204E-9DDB-43F1-A494-85559CFB028CQ28389056-0F903EE2-0541-4B5B-A71B-733952A4168BQ28389565-69E1F96F-60EB-4C26-8D9F-CC28A0EF5CA8Q28389927-129F782B-AA06-47F6-8A9B-8DAAD51A1E61Q28391334-9830F146-4284-46AE-98CD-4874C3AA737BQ28392035-115821FC-37BA-4AD7-9EC9-B18BFB8CD64FQ28392986-A51E13D4-51CA-46A2-ADA5-23302C091276Q28393194-D7FE1984-8157-4D20-83BD-2DBEED12B72BQ28394050-6F430E28-844F-479D-AEDB-21F3EA2EFBB4Q28394673-80648BA3-07CF-4CA7-9062-EAFA051C6CF6Q28394762-CF04B5B7-1418-4D89-A277-8ECBCF66787DQ28395806-A8A479D8-26E4-4BE7-99D0-FCA6FC6BB1B4Q29247857-B7E52788-0810-4C18-9E8A-7133D82EDA85Q33596330-3F97071A-E97E-469E-ACA2-82BE23078074Q33827649-4D8067C9-093E-47FE-ACF1-C6CB74FDF4C4Q34721457-862A8FCA-121F-4043-A5C5-CA34E46DBBC3Q35569215-C58A35D5-6A7D-4711-9CE0-9E0DB3EDE14EQ36104919-2E8B7ADB-3FA4-42E7-BA7E-EF2E4774DDE4Q38285750-B12F38AD-436B-4215-9CC8-A0D683FFD40DQ38595356-252E5470-A89F-4A58-BDD1-81FA8192F54CQ38653814-AA3BC1AD-4996-4A08-B80D-EAD4832DEF34Q38665194-08716524-3881-4DA1-85A3-1587461D3699Q38718577-87CFBBF2-EEAE-4D14-9B1E-45979D1399C9Q38720318-D7F8CFC3-96EB-4336-B5E2-762E1957BAEBQ38720595-E21DD0F2-6671-42B9-A76D-9D04FAE67FADQ38794513-1E93EC54-6A6E-408A-95F1-790C9CB10268Q38819505-F7D6191A-D969-4128-930F-BA50D77EF411
P2860
An integrated approach for the in vitro dosimetry of engineered nanomaterials
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@ast
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@en
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@nl
type
label
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@ast
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@en
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@nl
prefLabel
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@ast
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@en
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@nl
P2860
P3181
P356
P1476
An integrated approach for the in vitro dosimetry of engineered nanomaterials
@en
P2093
Joel M Cohen
Justin G Teeguarden
P2860
P2888
P3181
P356
10.1186/1743-8977-11-20
P407
P577
2014-05-01T00:00:00Z
P5875
P6179
1007642560